Aris Global and QED Solutions Join Forces To Give Customers Powerful Research and Investigation Capabilities.Business Editors & Health/Medical Writers BIOWIRE2K STAMFORD, Conn.--(BW HealthWire)--June 19, 2002 Aris Global, 15-year-veterans of developing innovative software solutions that accelerate the drug development lifecycle and assure global regulatory compliance, announce their strategic alliance with QED QED abbr. Latin quod erat demonstrandum (which was to be demonstrated) QED which was to be shown or proved [Latin quod erat demonstrandum] Noun 1. Solutions, the pioneer in software solutions to facilitate the identification, analysis and validation of signals leading to the early detection of possible drug safety issues. With this alliance, Aris Global users have access to a full suite of sophisticated analytic tools providing powerful research and investigation capabilities for drug safety professionals to analyze both clinical and post-market adverse drug event data. "In order to create a world class pharmacovigilance capability, we chose to enhance our systems with sophisticated analytic tools - like Qscan. Tools that could give our customers superior insight into the valuable safety data that they already have within our ARISg(TM) system," says Deepak Abbhi, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Aris Global. Victor Gogolak, CEO of QED says, "Aris Global is not just an alliance for us. It is a key partner for our entire offering, namely Qscan PRO for analyzing internal clinical and post-market data, as well as access to similar tools to analyze FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. and world data. Their ability to understand the complexity of global regulatory compliance, combined with their proven ability to develop leading solutions to manage adverse drug events, offers us a powerful, seamless, end-to-end pharmacovigilance solution for our customers." About Aris Global Aris Global (www.arisglobal.com) specialists in Drug Safety, Post-Marketing and Regulatory Applications since 1987, develops and deploys integrated software Separate software components or applications that have been combined into one package. See integrated software package. solutions for the pharmaceutical, biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. and medical device industries to accelerate the drug development lifecycle (e.g. globalTRIALS(TM), OC Connect, ClinTALK(TM)) and assure global regulatory compliance. (e.g., ARISg(TM), ARISg Workflow(TM), ARISg Safety Data Mart A subset of a data warehouse for a single department or function. A data mart may have tens of gigabytes of data rather than hundreds of gigabytes for the entire enterprise. See data warehouse. (TM), ARISg Signals(TM), ARISg Alerts(TM), Aris Global E2B E2B Education to Business Gateway(TM) and REGISTER(TM)), Aris Global also provides value-added consulting, validation, training, system implementation, data-migration and custom design services. About QED Solutions, Inc. QED Solutions (www.qedrx.com) specializes in developing analytic tools and automated statistical alerting to efficiently manage risks related to drug safety issues. QED is dedicated to designing, developing and delivering products that provide the latest innovations and state-of-the art solutions in support of pharmacovigilance and drug safety surveillance practices for both pharmaceutical and biotech bi·o·tech n. Informal Biotechnology. biotech Noun short for biotechnology Noun 1. companies. Its proprietary Qscan(TM) product monitors both company proprietary adverse event data and publicly available data sources. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion